(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 21.28% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Eli Lilly & Co's revenue in 2024 is $34,124,100,000.On average, 7 Wall Street analysts forecast LLY's revenue for 2024 to be $39,081,701,509,576, with the lowest LLY revenue forecast at $38,525,234,847,769, and the highest LLY revenue forecast at $39,474,981,227,410. On average, 7 Wall Street analysts forecast LLY's revenue for 2025 to be $48,857,266,088,950, with the lowest LLY revenue forecast at $46,833,605,839,080, and the highest LLY revenue forecast at $51,533,820,440,038.
In 2026, LLY is forecast to generate $57,672,763,602,405 in revenue, with the lowest revenue forecast at $55,042,076,539,908 and the highest revenue forecast at $60,679,402,233,624.